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ABSTRACT
GeneSigDB (http://www.genesigdb.org or http://
compbio.dfci.harvard.edu/genesigdb/) is a database
of gene signatures that have been extracted and
manually curated from the published literature.
It provides a standardized resource of published
prognostic, diagnostic and other gene signatures
of cancer and related disease to the community so
they can compare the predictive power of gene
signatures or use these in gene set enrichment
analysis. Since GeneSigDB release 1.0, we have
expanded from 575 to 3515 gene signatures, which
were collected and transcribed from 1604 published
articles largely focused on gene expression in
cancer, stem cells, immune cells, development and
lung disease. We have made substantial upgrades
to the GeneSigDB website to improve accessibility
and usability, including adding a tag cloud browse
function, facetted navigation and a ‘basket’ feature
to store genes or gene signatures of interest. Users
can analyze GeneSigDB gene signatures, or upload
their own gene list, to identify gene signatures
with significant gene overlap and results can be
viewed on a dynamic editable heatmap that can be
downloaded as a publication quality image. All data
in GeneSigDB can be downloaded in numerous
formats including .gmt file format for gene set
enrichment analysis or as a R/Bioconductor data
file. GeneSigDB is available from http://www.
genesigdb.org.
INTRODUCTION
Accurately curated and annotated gene sets have emerged
as essential tools for the analysis of large, complex bio-
logical datasets. Gene set analysis (GSA) is widely used in
the analysis and interpretation of gene expression proﬁling
data (1–4), evolutionary relationships (5), genomic associ-
ations—including QTL analysis (6), genotyping (7) and
SNP chips (8)—and even for cross platform integration
of genomics data (9). GSA aims to ﬁnd sets of genes
that collectively distinguish two phenotypes, even if
the genes in the set are not signiﬁcantly different when
tested individually. This reﬂects the fact that genes
within the cell function as members of complex networks
and pathways, often with multiple, overlapping functions.
As a result, direct comparisons of genes may miss bio-
logically important connections that are only seen when
these related genes are assessed collectively.
Gene sets have also become invaluable tools for char-
acterizing and distinguishing phenotypic states. In breast
cancer, for example, several gene expression signatures
have been developed as commercial diagnostic assays
(10) and new methods are being developed that combine
the predictive strength of multiple gene signatures to
increase their prognostic power (11).
Gene set resources can be broadly divided into those
which assign a gene to collections based on ‘known’
gene or protein interactions or functional activity and
those that include gene lists from high-throughput experi-
mental assays. Functional and pathway databases such as
Gene Ontology (GO), KEGG and Reactome capture pub-
lished descriptions of cellular pathways and gene functions
(12), including, in the case of GO, functional predictions
inferred from orthologous sequences (13). However, these
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comprehensively and completely catalog the functions
of all genes in the genome (13).
High-throughput experiments, such as microarray
expression proﬁling and RNA-seq have also produced
large numbers of potentially informative gene lists. Most
genomics papers present one or more gene signatures
that reportedly correlate with experimental phenotypes.
While there has been some controversy over the value
of individual gene sets, due to the fact that many fail to
fully replicate in independent data sets, the analysis of the
collected gene lists deﬁned for similar phenotypes has
been demonstrated to provide meaningful biological
insight (14).
Despite tremendous interest in using gene signatures,
public repositories such as GEO and ArrayExpress
(15,16) store primary gene expression data but fail to
capture the gene sets that are the end product of published
analyses. Without a systematic way of reporting these, the
gene sets often appear only in published tables or ﬁgures
or in supplementary materials hosted on the author’s
or the journal’s website. And as there are no accepted
standards for reporting gene sets, they often appear with
non-standard gene identiﬁers, making comparison to
other lists, or even to the original data, a signiﬁcant
challenge. Because of these limitations, gene sets from
published research studies are often inaccessible to auto-
mated computational analysis.
In August 2009, we created GeneSigDB (17) as a reposi-
tory for gene sets that had been systematically collected
and manually curated from published articles indexed by
PubMed. Our approach in building GeneSigDB was to
capture gene signatures from the literature as published,
to map them to standard identiﬁers using transparent,
reproducible protocols and to freely provide these to the
research community together with some elementary
analytical tools. Since its launch, GeneSigDB had 7918
web hits with 4404 hits in 2010 and 3354 so far this
year, suggesting that this resource is of value to the
biomedical research community.
GROWTH OF GENESIGDB DATABASE
GeneSigDB has grown considerably since its introduction
(Figure 1), nearly doubling in size with each subsequent
release. GeneSigDB 4.0, released in September 2011,
contains 3515 human, mouse and rat gene sets curated
from 1604 published articles. While we have continued
to focus on gene sets related to cancer and stem cells,
we now also include signatures for development, inﬂam-
mation and immune regulation, and lung disease and we
have begun to catalog signatures for miRNA expression
and proteomics. The content of GeneSigDB and its
composition are summarized in Tables 1 and 2.
GeneSigDB had minimal overlap with other gene
signatures resources when we compared the overlap of
publications curated by MSigDB (18) and CCancer (19)
to GeneSigDB. Only 198/1604 (12%) publications were
curated by both GeneSigDB (n=1604) and MSigDB
(n=786, Release 3.0). GeneSigDB and MSigDB are
both manually curated, but CCancer gene lists are com-
putationally extracted from publications in 100 journals
indexed by PubMed (19), and 30% of publications in
CCancer are also manually curated in GeneSigDB.
To estimate of curation quality, we examined 121 publi-
cations that were curated by all three gene signatures
resources. The number of gene signatures identiﬁed
in these 121 publications were 428287 and 123 by
MSigDB, GeneSigDB and CCancer respectively.
MSigDB and GeneSigDB captured more data per
publication that the automated curation of CCancer.
GENE SIGNATURE COLLECTION AND CURATION
PIPELINE
The primary data objects in GeneSigDB are genes,
published articles and gene signatures from those publica-
tions. We deﬁne a gene signature as a set of gene identiﬁers
that were experimentally derived from analysis of gene,
protein or miRNA expression.
Published articles likely to contain gene signature are
identiﬁed using predeﬁned PubMed searches as described
at http://compbio.dfci.harvard.edu/genesigdb/documenta-
tion.jsp. We download and read each article, identify
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Figure 1. Growth of GeneSigDB. GeneSigDB has grown considerably
over 4 database releases (August 2009, March 2010, December 2010,
September 2011). The most recent release (Release 4.0, September 2011)
contains 3515 human, mouse and rat gene sets curated from 1604 pub-
lished articles.
Table 1. Number of processed articles and extracted gene signatures
(by species) in GeneSigDB
Human Mouse Rat Total
Gene Signatures 2951 493 71 3515
Publications (PMIDs) 1368 208 39 1604*
Genes (EnsEMBL gene IDs) 20478 16009 5110
*There were 10 articles with human and mouse gene signatures, and 1
article with human and rat gene signatures.
Nucleic Acids Research, 2012,Vol. 40,Database issue D1061tables or ﬁgures containing gene signatures, and transcribe
these from the main body of the article, its supplementary
materials or websites referenced within the article
(Figure 2). We manually transcribe the entire table and
then use a pipeline based on Biomart (20) to map the
published gene identiﬁers to EnsEMBL IDs, creating
standardized gene sets.
The number of genes in the standardized sets may not
be equal to that reported in the source publication and this
may occur for a variety of reasons. Gene identiﬁers
reported in the article maybe have been retired, reported
probes may now be recognized as non-speciﬁc or they may
map to multiple genes, or gene identiﬁers maybe invalid
due to inaccurate reporting or to MS Excel gene name
conversion errors (21). GeneSigDB users have the option
of seeing either the original or standardized versions of
a gene set and in the current release version users can
compare the original and standardized lists side-by-side.
In addition, we have improved the visibility of unmapped
genes so that users can identify unmapped genes in
a GeneSigDB standardized table
Gene signatures in the database are identiﬁed by unique
SigIDs and SigNames. The SigIDs combine the PubMed
ID of the paper from which the signature was derived and
the table or ﬁgure in which it was reported. For example,
SigID 11823860-SuppTable2 refers to a gene signature
obtained from Table 2 in the supplementary material
from an article with PMID 11823860. The SigName is
designed to be a more descriptive, human-readable iden-
tiﬁer; the SigName associated with 11823860-SuppTable2
is Breast_van’tVeer02_231genes_PoorPrognosisSignature,
which indicates it is a signature of poor prognosis in breast
Figure 2. Overview of the GeneSigDB Data Curation pipeline. Gene signatures in tables or ﬁgures are transcribed from published articles indexed
in PubMed and we then use a pipeline based on Biomart (20) to map all published gene identiﬁers to EnsEMBL IDs, to create standardized gene
sets.
Table 2. Most common disease MeSH terms associated with articles
in GeneSigDB
a
MeSH Terms Publications
Breast neoplasms 248
Lung neoplasms 97
Prostatic neoplasms 73
Disease progression 69
Neoplasm metastasis 66
Ovarian neoplasms 66
Adenocarcinoma 65
Cell transformation, neoplastic 62
Neoplasm invasiveness 62
Carcinoma, squamous cell 58
Liver neoplasms 56
Carcinoma, hepatocellular 51
Lymphatic metastasis 42
Colonic neoplasms 38
Neoplasms 37
Precursor cell lymphoblastic leukemia–lymphoma 37
Stomach neoplasms 35
Neovascularization, pathologic 34
Disease models, animal 33
Genetic predisposition to disease 32
Pancreatic neoplasms 30
Chromosome aberrations 29
Carcinoma 28
Leukemia, myeloid, acute 28
Brain neoplasms 27
Carcinoma, non-small-cell lung 27
Leukemia, myeloid 25
Neoplasm recurrence, local 25
Leukemia, lymphocytic, chronic, B-cell 24
aRanking of Diseases MeSH Terms (MeSH preﬁx code category C)
associated with 1552 publications in GeneSigDB. A total of 63 publica-
tions were not annotated with MeSH Terms. More details are provided
in documentation on the GeneSigDB website.
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Veer and colleagues in 2002.
BROWSING AND SEARCHING GENESIGDB
We provide two search tools for ﬁnding signatures in the
database, one based on publications and the other based
on genes. The publication search tool allows users to enter
one or more search terms, such as author name, article
title, journal name or keywords (such as disease type), and
these are then searched against the full text of articles
represented in the database to ﬁnd those best meeting
the search criteria. In release 4.0 we added the ability to
search Medical Subject Headings (MeSH) terms
associated with each publication.
Users can also search for genes and their annotated
properties, including gene names and synonyms, function-
al classiﬁcations such as GO terms, InterPro domains,
KEGG or Reactome Pathways or almost any valid gene
identiﬁers including gene symbol, Entrez gene ID,
EnsEMBL gene ID, RefSeq ID or common commercial
microarray probe IDs.
Results can be further reﬁned by applying additional
search criteria or using faceted terms associated with pub-
lication or gene search results (Figure 3). For either
gene-based or publication-based searches, users can
collect their results and load these into a ‘Shopping
Basket’, allowing the signatures to be collected signatures
using a variety of independent criteria and to then viewed,
downloaded or compared (Figure 3).
DATA VIEWS
Clicking on a publication, gene or gene signature will open
up a data type-speciﬁc view for each of these. The publi-
cation view provides information about the published
article, its authors, an abstract and a list of gene signatures
associated with that publication. The gene view provides
annotation on a gene and a list of gene signatures which
contain that gene. Each of these pages includes links to
one or more gene signatures. The gene signature view now
provides a dynamic table presenting both the original and
standardized gene lists, each of which can be used to
sort and ﬁlter the signature.
COMPARING GENE SIGNATURES
One common question is whether a particular gene set
overlaps with others that have been reported. For pub-
lished gene lists, we have pre-computed the pairwise
similarity between all gene signatures using a one-tailed
Fisher’s exact test (which is equivalent to a hyper-
geometric distribution test) with P-values corrected for
multiple testing. When a user clicks ‘Related Signatures’
from a gene signature view, or ‘Compare’ gene signatures
in the Shopping Basket the most similar signatures are
presented both in list and graphical form (Figure 4).
Figure 3. Screenshot showing the (A) faceting and the (B) ‘Shopping Basket’ search features when we performed a publication search for ‘serous
ovarian cancer’ that returned a list of 11 publications. Further detail about (C) publications or (D) Signature can be viewed by clicking on their
respective links. By default 10 results are shown but up to 100 search results can be viewed. Selecting ‘Add All’ will add the 15 gene signatures
associated with the 11 displayed publications to the basket so they can be compared or downloaded.
Nucleic Acids Research, 2012,Vol. 40,Database issue D1063A heatmap is used to visualize the overlaps of genes in a
selection of gene signatures. In the heatmap, gray pixels
indicate no overlap and red indicates two signatures
sharing a common gene. Users can reorder, add or
remove genes or gene signatures from the heatmap
or use a sliding selector to deﬁne a minimum number of
genes required for overlap. Users can also edit the
heatmap column and row labels and export the heatmap
as a publication quality image.
Those wishing to compare their own gene lists to the
published lists in GeneSigDB can select ‘Analyze My
Genes’ from the top menu bar. This brings up an interface
that allows them to paste in their own gene list or to
upload a ﬁle containing a gene list. If the gene list is not
a list of EnsEMBL IDs, it is converted using BioMart,
tested for overlap with the gene sets in the database, and
reported using the table and heatmap views described
above.
DOWNLOADING GENESIGDB DATA
As described above, users may perform a search to create
a custom selection of gene signatures in their basket and
these can be downloaded as a compressed ﬁle. In addition,
all of the data in GeneSigDB is freely available for
download. Users selecting ‘Download’ from the top
menu bar are taken to a page where they can download
the current release and previous versions of the database.
The data are available in a variety of formats, including
a tab-delimited ﬂat ﬁle, GSEA gmt format and as an
R/Bioconductor RData ﬁle.
PROGRAMMATIC ACCESS TO GENESIGDB DATA
Release 4.0 of GeneSigDB includes expanded program-
matic access to the database through a Java RESTful
web service. We use the reference implementation of
JAX-RS found at Glassﬁsh (Jersey: https://jersey.dev
.java.net) to provide the REST HTTP functionality
and use the Glassﬁsh reference implementation of JAXB
(JAXB: https://jaxb.dev.java.net), for the XML trans-
formation. GeneSigDB provides REST services to
retrieve each of the major objects in GeneSigDB
(GeneSignature, Gene and Publication) along with all of
their ancillary member objects. These objects are in either
XML or JSON format. The REST request is made over
HTTP by creating a URL with an embedded key that will
then GET the speciﬁed resource. The Accepts portion of
the HTTP request header will determine the MIME (and
format) of the response. Further details and examples of
how these queries should be constructed are available in
GeneSigDB online documentation.
Figure 4. Screen shots of the ‘Analyze My Gene Lists’ and ‘Comparison View’. The gene overlap between 15 serous ovarian cancer gene signatures
selected in Figure 3 were analyzed. (A) shows the gene overlap between signature, where presence and absence of a gene are indicates by a red or gray
pixel in the heatmap. The image can be edited, reordered or genes and gene signatures can be added or removed before the image is exported as a
publication quality image. (B) shows results of a Fisher’s exact test of enrichment between the 15 gene signatures. These results can also be visualized
as a list.
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In building GeneSigDB, we chose to report the published
signatures rather than attempt to re-analyze the original
data described in each of the manuscripts we extract from
PubMed. Not only is re-analysis technically challenging
because of incomplete metadata, but there are other
projects that attempt to do this including Oncomine,
Exalt (22) the Gene Expression Atlas (GXA) project (23)
and our OncoSurf project, which is focused on ﬁnding
signatures that predict survival (http://cccb.dfci.harvard.
edu/oncosurf/).
The most comprehensive resource is GXA (http://www
.ebi.ac.uk/gxa) whose developers have reanalyzed over
5500 gene expression and RNA-sequencing studies to
identify expression proﬁles in 19000 cellular or clinical
phenotypes. In partnership with GXA, we are providing
‘link out’ access to GXA, providing visualization of the
GeneSigDB gene sets so that users can easily see which
genes within a signature are signiﬁcantly associated with
speciﬁc phenotypes in GXA.
SUBMITTING DATA FOR PUBLICATION IN
GENESIGDB
Although we have been accepting submission to
GeneSigDB by email, Release 4.0 includes a web form
for signature submission. Users can also use this form to
suggest updates to gene signatures currently in
GeneSigDB.
USER CASES STUDIES
Although GeneSigDB is a relatively new database, it has
already been used to advance our understanding of cancer
and disease in new and interesting ways. Abba and
colleagues used GeneSigDB 2.0 to retrieve breast cancer
gene signatures (n=42) to identify the 117 most common
genes across those signatures. They found the common
genes to be enriched for those associated with response
to steroid hormone stimulus, and the cell cycle. Their
meta-signature of the 42 GeneSigDB gene signatures was
capable of predicting overall survival (P<0.0001) and
relapse-free survival (P<0.0001) in patients with
early-stage breast carcinoma. GeneSigDB has also been
used to develop methods for Transcription factor
binding site analysis (24) and graph theory algorithms (25)
ARCHITECTURE OF WEB INTERFACE TO
GENESIGDB
The web interface to GeneSigDB (http://compbio.dfci
.harvard.edu/genesigdb) is based on HTML, CSS,
Javascript, JSP, XML and Java 1.6 technologies. The
application runs on an Apache Tomcat 6 web application
server running on a CentOS 5 Linux server. Front-end
interactivity makes use of the jQuery 1.4+ Javascript
library and server-side processing is based on the
Apache Solr Enterprise Search Server 1.4. GeneSigDB is
based on a hybrid approach between traditional database
technologies and Solr indexes to catalog and organize the
data. Search functions are performed using the Solr server
to create a high-performance search engine. Other site
functions are often performed using a database backend.
Both the database and the indexes contain the same infor-
mation, but they are organized in different ways to take
advantage of the relative strengths of each technology.
SUMMARY AND FUTURE DIRECTIONS
GeneSigDB addresses the important need within the com-
munity to standardize gene expression signatures so they
can easily be compared to each other and used in GSA.
The current release represents an almost 8-fold increase in
the number of gene sets from the ﬁrst version and includes
3515 gene signatures derived from the analysis of cancer,
stem cells, immune system function, development and lung
disease; at present it is the largest source of cancer-speciﬁc
gene signatures available. Based on the needs of our users,
we have made considerable efforts to increase the func-
tionality of the GeneSigDB website to facilitate mining
and analysis of gene signatures.
In the future, we hope to expand GeneSigDB function-
ality to provide links so that users can analyze connections
between genes using our predictive networks application
(http://www.predictivenetworks.org) and test whether
a gene signature is prognostic or associated with a
known SNP using OncoSurf (http://cccb.dfci.harvard
.edu/oncosurf).
Although there have been other attempts to catalog
gene sets, we believe that GeneSigDB represents a signiﬁ-
cant advance in both the quantity of gene signature data
we have amassed and the quality of the analysis we
perform. By standardizing both the way we refer to
these gene sets and the manner in which they are
mapped to standard formats, we have created an infra-
structure that can be scaled and extended to capture the
growing number of genomic proﬁles that are being created
and published. In a time when we as a community have
become aware of the need for reproducible research, such
standardization is essential to assure that the results
of genomic studies can be broadly used and replicated in
independent analysis. Further, the availability of stan-
dardized signatures creates an opportunity for us to
more fully leverage the prior knowledge that has been
gained by expert analysis of individual studies so that we
can more rapidly advance our understanding of the nature
of a broad range of human diseases.
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